Transformation of approaches to immunosuppressive therapy of IgA nephropathy: from systemic non‑specific to targeted drugs (Part 1)
IgA nephropathy (IgAN) is the most common primary chronic glomerulonephritis worldwide and a major cause of kidney failure requiring kidney replacement therapy. Current evidence indicates that its prognosis is considerably worse than previously assumed, while the proteinuria threshold associated with unfavorable outcom...